Evozyne, a portfolio company of Paragon Biosciences, announced that a peer-reviewed publication in the journal Science demonstrates successful use of its world-class molecular engineering technology to create never-before-seen proteins with exceptionally advanced functionality. The Chicago-based… Read more
CHICAGO–(BUSINESS WIRE)–May 13, 2019– Paragon Biosciences, LLC Chairman and CEO Jeff Aronin was recently recognized by the Northern Illinois University (NIU) College of Business as the 2019 recipient of their Innovation and Entrepreneurship Award. This press release… Read more
CHICAGO–(BUSINESS WIRE)–Paragon Biosciences Chairman and CEO Jeffrey S. Aronin won a 2019 BIG Innovation Award presented by the Business Intelligence Group. The award honors executives whose leadership improves quality of life. Read the full article… Read more